Application Nr Approved Date Route Status External Links
ANDA077314 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Nizatidine Capsules Are Indicated For Up To 8 Weeks For The Treatment Of Active Duodenal Ulcer. In Most Patients, The Ulcer Will Heal Within 4 Weeks. Nizatidine Capsules Are Indicated For Maintenance Therapy For Duodenal Ulcer Patients At A Reduced Dosage Of 150 Mg H.s. After Healing Of An Active Duodenal Ulcer. The Consequences Of Continuous Therapy With Nizatidine For Longer Than 1 Year Are Not Known. Nizatidine Capsules Are Indicated For Up To 12 Weeks For The Treatment Of Endoscopically Diagnosed Esophagitis, Including Erosive And Ulcerative Esophagitis, And Associated Heartburn Due To Gerd. Nizatidine Capsules Are Indicated For Up To 8 Weeks For The Treatment Of Active Benign Gastric Ulcer. Before Initiating Therapy, Care Should Be Taken To Exclude The Possibility Of Malignant Gastric Ulceration.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Nizatidine NIZATIDINE ZINC1530736

Comments